vTv Therapeutics Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from vTv Therapeutics Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 83% of its market value (net cash). Higher than 85% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 100%
Sales fell 100% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-100% / +170%In 3 years sales changed by -100% while total assets changed by +170%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
No debt dueNo debt falls due within a year, according to the latest yearly balance sheet.
Cash Cushion Ratio
+83%Cash, after subtracting all debt, equals 83% of its market value (net cash).
Higher than 85% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
vTv Therapeutics Inc. made a loss over the last year. vTv Therapeutics Inc. owes $0.10 for every $1 it owns. vTv Therapeutics Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossvTv Therapeutics Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.37The share price is 1.37 times vTv Therapeutics Inc.'s book value per share, lower than 71% of Healthcare companies in United States.
Market cap
$107 MThe total market value of all of vTv Therapeutics Inc.'s shares at today's price (share price × number of shares), smaller than 64% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$79 MWhat vTv Therapeutics Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$19.89Net worth divided by the number of shares. The share price of $27.16 is 1.4 times this, which is the P/B above.
Return on equity (ROE)
-15.8%vTv Therapeutics Inc. lost 15.8% of its shareholders' money over the last year, higher than 68% of Healthcare companies in United States.
Owes vs Owns
0.10×vTv Therapeutics Inc. owes $0.10 for every $1 it owns (low), lower than 86% of Healthcare companies in United States.
Dividend yield
NonevTv Therapeutics Inc. does not currently pay a dividend.
Profit growth
LossvTv Therapeutics Inc. made a loss in each of the last two years.
Interest cover
Not coveredvTv Therapeutics Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashvTv Therapeutics Inc. held $89 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For vTv Therapeutics Inc.: $107 M ÷ $79 M (30 Jun 2026) = 1.4.
What is vTv Therapeutics Inc.'s return on equity?
vTv Therapeutics Inc. lost 15.8% of its shareholders' money over the last year, higher than 68% of Healthcare companies in United States.
How much does vTv Therapeutics Inc. owe compared with what it owns?
vTv Therapeutics Inc. owes $0.10 for every $1 it owns (low), lower than 86% of Healthcare companies in United States.
Does vTv Therapeutics Inc. pay a dividend?
No. vTv Therapeutics Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.